Healthpeak Properties (NYSE:DOC - Get Free Report) was upgraded by equities research analysts at StockNews.com from a "sell" rating to a "hold" rating in a report released on Saturday.
Several other research firms also recently weighed in on DOC. Scotiabank dropped their target price on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research report on Friday, February 28th. Wedbush cut their price objective on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating on the stock in a research report on Friday, February 14th. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price for the company in a report on Wednesday, January 15th. Wells Fargo & Company reduced their price target on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 10th. Finally, Mizuho cut their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research note on Thursday, December 5th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $23.92.
Get Our Latest Research Report on DOC
Healthpeak Properties Trading Down 1.4 %
Healthpeak Properties stock traded down $0.29 during trading on Friday, hitting $20.16. The company had a trading volume of 4,378,232 shares, compared to its average volume of 4,629,563. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company's 50 day simple moving average is $20.25 and its 200-day simple moving average is $21.15. Healthpeak Properties has a 1-year low of $17.45 and a 1-year high of $23.26. The stock has a market cap of $14.10 billion, a price-to-earnings ratio of 57.60, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14.
Institutional Trading of Healthpeak Properties
Hedge funds have recently made changes to their positions in the company. State Street Corp purchased a new position in shares of Healthpeak Properties during the 3rd quarter worth approximately $1,093,576,000. JPMorgan Chase & Co. boosted its holdings in Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Geode Capital Management LLC grew its position in Healthpeak Properties by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust's stock worth $371,168,000 after buying an additional 638,012 shares during the period. Principal Financial Group Inc. grew its position in Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after buying an additional 17,314,572 shares during the period. Finally, Fuller & Thaler Asset Management Inc. increased its holdings in Healthpeak Properties by 10.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust's stock valued at $350,021,000 after buying an additional 1,651,235 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.